Fig. 6

sFgl2-MSCs increased the proportions of Tregs in the spleen and liver in AIH mice and decreased the proportions of Th17 and Th1 cells. A Dot plots showing Tregs among CD4⁺ T cells in the spleen and liver. B Dot plots showing Th17 cells among CD4⁺ T cells in the spleen and liver. C Dot plots showing Th17 cells among CD4⁺ T cells in the spleen and liver. D The proportions of Tregs in the spleen and liver in the different groups, n = 6. E The proportions of Th17 cells in the spleen and liver in the different groups, n ≥ 5. F The proportions of Th1 cells in the spleen and liver in the different groups, n ≥ 5. The differences between groups were calculated using ANOVA. *: P < 0.05, **: P < 0.01, ***: P < 0.001. Abbreviations: MSCs, mesenchymal stem cells; sFgl2, soluble fibronectin-like protein 2; WT-MSCs, wild-type MSCs; NC-MSCs, negative control MSCs